Published
At the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium, Sia Daneshmand, MD, of University of Southern California, provides overviews and updates from three clinical trials involving cretostimogene for high-risk NMIBC: CORE-008, BOND-003, and PIVOT-006.
- Categoria
- Oncology
Commenta per primo questo video.
Prossimo
-
15:01
High Lipoprotein(a) (Lp(a)) — What It Means for Your Heart Risk #lipoproteina #lpa
-
17:01
High Lipoprotein(a): What It Means for Your Heart Risk (Living With High Lp(a) - Lesson 1 )
-
17:53
Navigating High-Risk Pregnancy with Multidisciplinary Cardio-Obstetrics Care
-
19:22
S. Katsianos | Case 2: PCI for high-risk/vulnerable plaque
-
08:22
BOND-003 With Dr. Mark D. Tyson: Cretostimogene for BCG-Unresponsive Bladder Cancer
-
08:33
The ABLE-32 Study: Nadofaragene Firadenovec for Intermediate-Risk NMIBC
-
04:54
Molecular Biomarkers and Risk Stratification in High-Risk Non-Muscle Invasive Bladder Cancer
-
10:15
CHIP-BCIS3: Left ventricular unloading in high-risk PCI
-
12:02
AI-Powered Biomarkers and Precision Medicine in High-Risk NMIBC
-
04:08
Cretostimogene for Bladder Cancer: BOND-003 Study Ramifications
-
09:07
Cardiology for Beginners: Basics of Heart Sounds and Murmurs (with examples)
-
13:45
How to Become a Cardiologist | Cardiac Electrophysiologist
-
04:14
V 00592 Cardiology Fellowship Video Dr Vranian V5
-
05:17
Cardiology Fellowship at SIU Medicine
-
04:15
Cardiology Fellowship Program at Danbury Hospital
-
05:49
Practice Question: Cardiology #1, USMLE Step 1, COMLEX Level 1
-
04:07
Dr. Muhammed Raza on advice for Fellows interested in Interventional Cardiology
-
07:36
Congenital Heart Disease – Cardiology | Lecturio
-
05:18
Cardiology Fellowship at IU School of Medicine
-
04:36
What are different types of Cardiology Tests | SPS Hospitals
